Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0478-2021Class II

RayStation standalone software treatment planning system, Model No. 4.0, 4.5, 4.7, 4.9, 5.0, 6.0, 6.1, 6.2...

RaySearch Laboratories AB (publ) / initiated 2020-10-08 / Terminated / root cause: software

RAYSEARCH LABORATORIES AB began a recall of RayStation standalone software treatment planning system, Model No. 4.0, 4.5, 4.7, 4.9, 5.0, 6.0, 6.1, 6.2, 6.3, 7.0, 8.0, 8.1, 9.0, 9.1, 9.2, 10.0 - Product... on . FDA classified it as Class II and gives the reason as "If a region of interest (ROI) or point of interest (POI) that is referenced from an imported plan is missing in the imported RT Structure Set, the reference may become linked to the wrong ROI or POI". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0478-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
RaySearch Laboratories AB (publ)
Product
RayStation standalone software treatment planning system, Model No. 4.0, 4.5, 4.7, 4.9, 5.0, 6.0, 6.1, 6.2, 6.3, 7.0, 8.0, 8.1, 9.0, 9.1, 9.2, 10.0 - Product Usage: RayStation is a software system for radiation therapy and medical oncology. Based on user input, RayStation proposes treatment plans. After a proposed treatment plan is reviewed and approved by authorized intended users, RayStation may also be used to administer treatments. The system functionality can be configured based on user needs.
Product code
MUJ System, Planning, Radiation Therapy Treatment
Reason for recall
If a region of interest (ROI) or point of interest (POI) that is referenced from an imported plan is missing in the imported RT Structure Set, the reference may become linked to the wrong ROI or POI.
Root cause tag
software
FDA root cause
Software design
Action
On October 8, 2020, the firm emailed "Field Safety Notice, Medical Device Correction #66704" to affected customers. Customers were made aware of the product issue and asked to take the following actions: " Do not exclude the prescription ROI or POI when exporting from RayStation with the Exclude from export option. " If an RT Structure Set where it is not certain that all referenced bolus and prescription ROIs or POIs are present is imported to RayStation, make sure to check that any intended references to bolus and prescription are correct after import. " Please educate planning staff and all users about this workaround. " Inspect your product and identify all installed units with the above software version number(s). " Confirm you have read and understood this notice by replying to the notification email. This issue will be resolved in the next version of RayStation, scheduled for market release in November 2020 (subject to market clearance in some markets). If customers wish to continue using versions of RayStation affected by this notice, all users must maintain awareness of this notice. Alternatively, customers can choose to upgrade to the new version once it becomes available for clinical use. For regulatory information, please contact [email protected]
Quantity in commerce
2768
Distribution
US Nationwide distribution.
Product codes and lots
Software version numbers:   4.0.0.14 , 4.0.3.4 , 4.5.1.14 , 4.7.2.5 , 4.7.3.13 , 4.7.4.4 , 4.7.5.4 , 4.7.6.7 , 4.9.0.42 ,; 5.0.1.11 , 5.0.2.35 , 5.0.3.17 , 6.0.0.24 , 6.1.1.2 , 6.2.0.7 , 6.3.0.6 , 7.0.0.19 , 8.0.0.61 , 8.0.1.10 , 8.1.0.47 , 8.1.1.8 8.1.2.5 , 9.0.0.113 , 9.1.0.933 , 9.2.0.483 , 10.0.0.1154

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0478-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0478-2021Class IITerminatedVoluntary: Firm initiated